SignatureFD’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.5K Hold
14,298
﹤0.01% 1850
2025
Q4
$46.5K Buy
14,298
+475
+3% +$1.6K ﹤0.01% 1695
2025
Q3
$39.7K Buy
13,823
+3,841
+38% +$9.81K ﹤0.01% 1762
2025
Q2
$24.1K Buy
9,982
+4,723
+90% +$9.93K ﹤0.01% 1969
2025
Q1
$11.6K Buy
5,259
+2,464
+88% +$9.74K ﹤0.01% 2296
2024
Q4
$15.2K Sell
2,795
-3,625
-56% -$23.3K ﹤0.01% 2200
2024
Q3
$53.4K Sell
6,420
-356
-5% -$3.08K ﹤0.01% 1541
2024
Q2
$48.5K Buy
6,776
+674
+11% +$5.82K ﹤0.01% 1526
2024
Q1
$52.9K Buy
6,102
+1,470
+32% +$9.95K ﹤0.01% 1522
2023
Q4
$30.3K Buy
4,632
+1,268
+38% +$8.19K ﹤0.01% 1716
2023
Q3
$33.6K Buy
3,364
+1,681
+100% +$18.5K ﹤0.01% 1599
2023
Q2
$20.9K Sell
1,683
-3,114
-65% -$42K ﹤0.01% 1861
2023
Q1
$67.2K Buy
4,797
+2,835
+144% +$40.7K ﹤0.01% 1238
2022
Q4
$28.1K Buy
1,962
+760
+63% +$12K ﹤0.01% 1640
2022
Q3
$31K Buy
1,202
+802
+201% +$20.1K ﹤0.01% 1532
2022
Q2
$11K Hold
400
﹤0.01% 2073
2022
Q1
$14K Hold
400
﹤0.01% 2006
2021
Q4
$17K Buy
400
+200
+100% +$8.1K ﹤0.01% 1858
2021
Q3
$10K Buy
+200
New +$9.76K ﹤0.01% 2072

Other funds holding MRVI

SignatureFD's MRVI Position: Q1 2026 in Review

SignatureFD held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 14,298 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1850.

SignatureFD first reported a position in MRVI in Q3 2021 and has held it in 19 quarters since. The position peaked at $67.2K in Q1 2023. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • SignatureFD held 14,298 shares of Maravai LifeSciences worth $40.5K as of Q1 2026.
  • SignatureFD left its Maravai LifeSciences share count unchanged in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1850 holding.
  • SignatureFD first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 19 quarters since.
  • SignatureFD's Maravai LifeSciences position peaked at $67.2K in Q1 2023.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.